Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Rescue of tropomyosin-induced familial hypertrophic cardiomyopathy mice by transgenesis.

American journal of physiology. Heart and circulatory physiology - 1 Aug 2007

Jagatheesan Ganapathy, Rajan Sudarsan, Petrashevskaya Natalia, Schwartz Arnold, Boivin Greg, Arteaga Grace M, Solaro R John, Liggett Stephen B, Wieczorek David F

Abstract excerpt

Familial hypertrophic cardiomyopathy (FHC) is a disease caused by mutations in contractile proteins of the sarcomere. Our laboratory developed a mouse model of FHC with a mutation in the thin filament protein alpha-tropomyosin (TM) at amino acid 180 (Glu180Gly). The hearts of these mice exhibit d...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Actin Cytoskeleton
Share to Adrenergic beta-Agonists

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cardiomyopathy, Hypertrophic, Familial

Share to Heart Rate

Share to Isoproterenol

Share to Myocardial Contraction

Share to Sarcomeres

Share to Tropomyosin

Source

Identifiers

PMID: 17416600
DOI: 10.1152/ajpheart.01341.2006

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17416600-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Rescue of tropomyosin-induced familial hypertrophic cardiomyopathy mice by transgenesis.PMID 17416600Read ↗

A familial hypertrophic cardiomyopathy alpha-tropomyosin mutation causes severe cardiac hypertrophy and death in mice.Semantic proximity Read ↗

Mouse model of a familial hypertrophic cardiomyopathy mutation in alpha-tropomyosin manifests cardiac dysfunction.Semantic proximity Read ↗

Cardiac dysfunction in hypertrophic cardiomyopathy mutant tropomyosin mice is transgene-dependent, hypertrophy-independent, and improved by beta-blockade.Semantic proximity Read ↗

Long-term rescue of a familial hypertrophic cardiomyopathy caused by a mutation in the thin filament protein, tropomyosin, via modulation of a calcium cycling protein.Semantic proximity Read ↗

Desensitization of myofilaments to Ca2+ as a therapeutic target for hypertrophic cardiomyopathy with mutations in thin filament proteins.Semantic proximity Read ↗

An internal domain of beta-tropomyosin increases myofilament Ca(2+) sensitivity.Semantic proximity Read ↗

Morphological and functional alterations in ventricular myocytes from male transgenic mice with hypertrophic cardiomyopathy.Semantic proximity Read ↗

Comparison of two murine models of familial hypertrophic cardiomyopathy.Semantic proximity Read ↗

Rescue of high expression beta-tropomyosin transgenic mice by 5-propyl-2-thiouracil. Regulating the alpha-myosin heavy chain promoter.Semantic proximity Read ↗

A mouse model of familial hypertrophic cardiomyopathy.Semantic proximity Read ↗

A truncated cardiac troponin T molecule in transgenic mice suggests multiple cellular mechanisms for familial hypertrophic cardiomyopathy.Semantic proximity Read ↗

Progression from hypertrophic to dilated cardiomyopathy in mice that express a mutant myosin transgene.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.